Next Article in Journal
Die Fontan-Konversion—Oder das Schicksal, Die Erste zu Sein
Previous Article in Journal
Neue Empfehlungen zur Antibiotischen Endokarditisprophylaxe: Pädiatrische Applikation
 
 
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Churg-Strauss Syndrome

by
Sina Lautwein
1,
Frank Enseleit
1,
Urs Schwarz
2 and
Thomas F. Lüscher
1,*
1
Cardiovascular Center Cardiology, University Hospital Zurich, Zurich, Switzerland
2
Department of Neurology, University Hospital Zurich, Zurich, Switzerland
*
Author to whom correspondence should be addressed.
Cardiovasc. Med. 2010, 13(10), 313; https://doi.org/10.4414/cvm.2010.01533
Submission received: 13 July 2010 / Revised: 13 August 2010 / Accepted: 13 September 2010 / Published: 13 October 2010

Abstract

A 62-year-old patient was admitted to our hospital because of severe fatigue, headache, arthralgias, myalgias and an unsteady gait. She presented with a reduced general condition and splinter haemorrhages of the fingers. Due to a known history of asthma, signs of eosinophilia, sinusitis, endomyocardial thrombotic apposition in both chambers and neurological deterioration, the diagnosis of multisystem vasculitis (ChurgStrauss syndrome) was made. The symptoms resolved after steroid therapy. Churg-Strauss syndrome is a rare necrotising systemic inflammatory vasculitis of the small and medium-size vessels. Typically, the disease has three distinct stages, which can possibly involve several organic systems (e.g., pulmonary, cardial, renal and nervous system). The treatment for ChurgStrauss syndrome includes steroids and/or other immunosuppressive drugs. After introduction of steroid therapy, the prognosis of the disease improves significantly, but heart failure remains as a major determinant of mortality.

Share and Cite

MDPI and ACS Style

Lautwein, S.; Enseleit, F.; Schwarz, U.; Lüscher, T.F. Churg-Strauss Syndrome. Cardiovasc. Med. 2010, 13, 313. https://doi.org/10.4414/cvm.2010.01533

AMA Style

Lautwein S, Enseleit F, Schwarz U, Lüscher TF. Churg-Strauss Syndrome. Cardiovascular Medicine. 2010; 13(10):313. https://doi.org/10.4414/cvm.2010.01533

Chicago/Turabian Style

Lautwein, Sina, Frank Enseleit, Urs Schwarz, and Thomas F. Lüscher. 2010. "Churg-Strauss Syndrome" Cardiovascular Medicine 13, no. 10: 313. https://doi.org/10.4414/cvm.2010.01533

APA Style

Lautwein, S., Enseleit, F., Schwarz, U., & Lüscher, T. F. (2010). Churg-Strauss Syndrome. Cardiovascular Medicine, 13(10), 313. https://doi.org/10.4414/cvm.2010.01533

Article Metrics

Back to TopTop